- Acumen Powered by Robins Kaplan LLP™
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
July 21, 2021Benchmark Litigation Names Patrick Arenz and Aaron Fahrenkrog to its 40 & Under Hot List in 2021
-
July 20, 2021Five Robins Kaplan Firm Members Recognized by Minnesota Lawyer
-
July 19, 2021Robins Kaplan Attorneys Recognized as 2021 Minnesota Super Lawyers and Rising Stars
-
July 26, 2021Tee It up for the Troops
-
August 5, 2021Domesticating an Out of State Judgment in The State of Florida
-
August 6, 2021Mastering the Deposition: 30(b)(6) Deposition Strategies and Updates 2021
-
July 15, 2021Biotechnology & Trade Secret Protection
-
July 6, 2021'Abuse of dominance': Was this what Congress originally intended for Section 2?
-
Summer 2021Family Feud: A Cautionary Tale of the Costs, Risks, and Uncertainty of Minority-Shareholder Litigation
-
July 23, 2021Financial Daily Dose 7.23.2021 | Top Story: Amazon Abruptly Drops Mandatory Arbitration Requirement
-
July 22, 2021Financial Daily Dose 7.22.2021 | Top Story: Drug Companies Strike $26B Deal with State AGs Over Opioid Crisis
-
July 21, 2021Financial Daily Dose 7.21.2021 | Top Story: White House Names Google Critic Kanter to Lead DOJ Antitrust Division
Find additional firm contact information for press inquiries.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Medtech Women: Business Model Innovation
Enhancing Value Creation through Disruption, Optimization, and Innovation
October 1, 2019
Robins Kaplan is proud to be the 2019-2020 presenting sponsor for the Medtech Women Minnesota chapter. At this event, hear from leaders in medtech on how to drive a business to the next level through the evolution of its operating model, innovative and global approaches, and ability to capture value in the marketplace.
Learn more about the Medtech Women Business Model Innovation event
Questions? Contact Christine Berndt at CBerndt@RobinsKaplan.com or 612.349.8404.
Agenda:
6:30 p.m. Networking
7:15 p.m. Introductions and Panel
8:45 p.m. Panel End
Moderator:
Heather Hudnut Page
Vice President and General Manager
Philips Healthcare Peripheral Vascular
Panelists:
Dr. Simone Ahuja
Innovation Strategist and Founder, Blood Orange Consulting;
HBR.org Columnist;
Best-Selling Author of Jugaad Innovation and Disrupt it Yourself
Erin Carnish
Managing Director and Chief Operating Officer
UnitedHealth Group Ventures
Ellie Humphrey
Vice President
Medtronic Enterprise Excellence and Business Transformation
Related Publications
July 15, 2021
Biotechnology & Trade Secret Protection
Sharon Roberg-Perez, David Prange, Ellen Levish - Bloomberg Law
July 6, 2021
'Abuse of dominance': Was this what Congress originally intended for Section 2?
Eamon O'Kelly, Vidya Dindiyal - Westlaw Today
Summer 2021
Family Feud: A Cautionary Tale of the Costs, Risks, and Uncertainty of Minority-Shareholder Litigation
Anne Lockner - The Robins Kaplan Spotlight, Vol. 6, No. 2
Summer 2021
In the Beginning: Choosing the Right Corporate Entity
Manleen Singh - The Robins Kaplan Spotlight, Vol. 6, No. 2
Summer 2021
Life After Settlement: Crafting Agreements to Avoid Future Disputes
Eric Magnuson, Tim Billion - The Robins Kaplan Spotlight, Vol. 6, No. 2
Related News
July 21, 2021
Related Events
July 26, 2021
August 5, 2021
August 6, 2021
Mastering the Deposition: 30(b)(6) Deposition Strategies and Updates 2021
Christine Yun Sauer - Bridgeport Continuing Education
Remote
August 19, 2021
September 23, 2021
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.